BILL ANALYSIS

S3350

BULLISH

ACO Assignment Improvement Act of 2025

S3350 (ACO Assignment Improvement Act of 2025) has been assessed with a bullish outlook for investors. This legislation directly affects Centene ($CNC), CVS Health ($CVS), Humana ($HUM) and Molina Healthcare ($MOH) and 1 other ticker. The primary sectors impacted are Healthcare. View the full bill text on Congress.gov.

bullish

Market Sentiment

Affected Stocks

Sectors Impacted

Key Takeaways for Investors

Expanded ACO attribution: NP/PA visits now count toward beneficiary assignment, directly growing the patient pool for ACO operators without requiring new provider hiring.

No direct spending authorized — impact comes from increased shared savings potential, not appropriations.

Bipartisan Senate sponsorship and a House companion bill provide moderate legislative momentum, but the bill remains in early committee stage.

All five named insurers (UNH, HUM, CVS, CNC, MOH) have rallied 16-63% in the last 30 days, reflecting broader sector tailwinds toward value-based care.

The mechanism is structurally bullish for ACO-heavy Medicare Advantage insurers long-term, but passage is not guaranteed in the 119th Congress.

How S3350 Affects the Market

The five major Medicare Advantage ACO operators have all posted strong 30-day gains as of April 30, 2026: UNH at $368.86 (+36.32%), HUM at $241.91 (+39.51%), CVS at $83.66 (+16.49%), CNC at $53.52 (+63.47%), and MOH at $195.17 (+46.41%). These moves likely reflect broader sector optimism on value-based care policy momentum rather than this specific early-stage bill. The structural benefit from expanded NP/PA attribution is clear but distant. Near-term price action will be driven by committee progress on S.3350 and HR4773, Medicare Advantage rate announcements, and broader managed care earnings. Investors should watch Senate Finance Committee scheduling and any CMS rulemaking that parallels this legislative direction.

Bill Details

Metric	Value
Bill Number	S3350
Market Sentiment	bullish
Event Date	December 4, 2025
Affected Sectors	Healthcare
Affected Stocks	Centene ($CNC), CVS Health ($CVS), Humana ($HUM), Molina Healthcare ($MOH), UnitedHealth Group ($UNH)
Source	View on Congress.gov →

Summary

The ACO Assignment Improvement Act of 2025 widens Medicare Shared Savings Program attribution to include NP and PA visits. This directly benefits ACO operators among major Medicare Advantage insurers (UNH, HUM, CVS, CNC, MOH) by expanding their addressable patient pool for shared savings without additional provider recruitment. The bill is at early legislative stage with a bipartisan Senate sponsorship, but the mechanism is structurally favorable for the sector.

Full AI Market Analysis

On December 4, 2025, Senator Barrasso (R-WY) introduced S.3350, the ACO Assignment Improvement Act of 2025, with one cosponsor (Sen. Whitehouse, D-RI). The bill was read twice and referred to the Senate Finance Committee. It remains in early legislative stage with no further action. The bill amends Section 1899(c)(1) of the Social Security Act to require CMS, starting in performance years on or after January 1, 2026, to assign Medicare fee-for-service beneficiaries to ACOs based on primary care services provided by nurse practitioners, physician assistants, and clinical nurse specialists — not only ACO physicians as under current law. This expands the attribution pool for all ACO operators. The bill does not authorize or appropriate any specific dollar amount. Its impact is regulatory — it changes how beneficiary assignment is calculated, increasing the number of patients attributed to each ACO. No direct government spending is triggered; instead, the mechanism unlocks potential shared savings revenue for ACOs that successfully coordinate care for a larger attributed population. The money trail runs through Medicare's shared savings distribution: ACOs that reduce costs below a benchmark receive a percentage of savings. Expanding attribution increases the numerator (patients eligible for savings) without increasing the denominator (provider requirements). Structural winners are Medicare Advantage insurers with large ACO operations: UNH (OptumCare network), HUM (pure-play MA), CVS (Aetna MA plus MinuteClinic NP visits directly counting), CNC (Centene's Medicare plans), and MOH (Molina's MA membership). Real market data shows these stocks have already rallied significantly in the 30 days preceding April 30, 2026: UNH +36.32%, HUM +39.51%, CVS +16.49%, CNC +63.47%, MOH +46.41%. While this rally predates any new legislative floor action on this specific bill, the sector's momentum aligns with growing focus on value-based care reimbursement expansion. The companion bill HR4773 has been referred to Ways & Means and Energy & Commerce, showing bicameral interest. Timeline: The bill has only one legislative action (referral to Senate Finance) since introduction. It requires committee markup, full Senate vote, House passage (companion HR4773), and presidential signature. Passage before 2027 is possible given bipartisan sponsorship and alignment with CMS's existing push toward value-based care, but the early stage means no near-term catalyst. Impact is moderate — structural support for the sector but no imminent law change.